[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371841-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371841-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","trend-and-cancer-specific-prevalence-of-kidney-stones-among-us-cancer-survivors-2007-2020","Trend and Cancer-Specific Prevalence of Kidney Stones Among US Cancer Survivors, 2007-2020","","Purpose: evaluate prevalence and cancer-specific patterns of kidney stones among U.S. cancer survivors versus non-cancer adults. Methods: serial cross-sectional epidemiologic analysis using National Health and Nutrition Examination Survey data from 2007 to 2020; weighted prevalence estimated by study cycle and multivariable logistic regression used to identify factors associated with higher kidney-stone probability. Results: prevalence increased in both groups from 2007-2008 to 2017-2020 and remained consistently higher in survivors; by 2020, 17.3% versus 9.2%, with adjusted odds OR=1.28. Cancer type-specific risks were elevated, with the highest numerically among kidney cancer.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/healthcare/","Healthcare",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/trend-and-cancer-specific-prevalence-of-kidney-stones-among-us-cancer-survivors-2007-2020/371841/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/trend-and-cancer-specific-prevalence-of-kidney-stones-among-us-cancer-survivors-2007-2020/371841.png","ImageObject",300,407,{"name":42,"@type":43},"Aldword","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the purpose of the study?","Question",{"text":63,"@type":64},"To evaluate the prevalence and cancer-specific patterns of kidney stones among U.S. cancer survivors compared to non-cancer adults.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were kidney-stone prevalence and associated factors analyzed?",{"text":68,"@type":64},"The study used serial cross-sectional NHANES data from 2007 to 2020, estimated weighted prevalence by survey cycle, and applied multivariable logistic regression to examine factors linked to kidney stones.",{"name":70,"@type":61,"acceptedAnswer":71},"How did kidney-stone prevalence change from earlier to later periods (2007–2008 to 2017–2020)?",{"text":72,"@type":64},"Kidney-stone prevalence rose in both non-cancer adults and cancer survivors, and it was consistently higher among cancer survivors throughout the study period.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371841,1790716217,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":108,"slug":109},7,40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},"Research & Report",30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":107,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":108},2336478940917,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Article  \nTrend and Cancer-Specific Prevalence of Kidney Stones Among US Cancer Survivors, 2007–2020  \nChao Cao 1, *,†, Ruixuan Wang 1,2,†, Xiangren Wang 2, Mohammad Abufaraj 3,4, Thomas Waldhoer 5, Geoffrey T. Gotto 6, Shahrokh F. Shariat 3,7,8 and Lin Yang 9,10  \nReceived: 8 August 2025  \nRevised: 27 August 2025  \nAccepted: 4 September 2025  \nPublished: 5 September 2025  \nCitation: Cao, C.; Wang, R.; Wang, X.; Abufaraj, M.; Waldhoer, T.; Gotto, G.T.; Shariat, S.F.; Yang, L. Trend and Cancer-Specific Prevalence of Kidney Stones Among US Cancer Survivors, 2007–2020. Curr. Oncol. 2025, 32, 498 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)curroncol32090498  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; [ruixuan_wang@dfci.harvard.edu](ruixuan_wang@dfci.harvard.edu)  \n2 Department of Health Service Research, Management and Policy, College of Public Health and Health Professions, University of Florida, Gainesville, FL 32611, USA  \n3 Department of Urology, Medical University of Vienna, 1009 Vienna, Austria; [dr.abufaraj@gmail.com](dr.abufaraj@gmail.com) (M.A.)  \n4 Division of Urology, Department of Special Surgery, Jordan University Hospital, The University of Jordan, Amman 11942, Jordan  \n5 Department of Epidemiology, Center for Public Health, Medical University of Vienna, 1009 Vienna, Austria; [thomas.waldhoer@meduniwien.ac.at](thomas.waldhoer@meduniwien.ac.at)  \n6 Southern Alberta Institute of Urology, Department of Surgery, University of Calgary, Calgary, AB T2N 1N4, Canada  \n7 Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA  \n8 Department of Urology, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, NY 10032, USA  \n9 Department of Cancer Epidemiology and Prevention Research, Cancer Care Alberta, Calgary, AB T2N 5G2, Canada  \n10 Departments of Oncology and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada  \n* Correspondence: [chao_cao@dfci.harvard.edu](chao_cao@dfci.harvard.edu); Tel.: +1-617-632-5702 † These authors contributed equally to this work.  \nSimple Summary  \nKidney stones are a painful and common condition, but their impact on people who have survived cancer is not well understood. This study analyzed national health survey data from 2007 to 2020, including over 40,000 adults without cancer and nearly 3500 cancer survivors in the US. We found that kidney stones became more common over time in both groups, but cancer survivors consistently had higher rates. By 2020, 17% of cancer survivors had experienced kidney stones, compared to 9% of non-cancer adults. Survivors of certain cancers, such as ovarian, kidney, bone and soft tissue, uterine, cervical, and prostate cancers, had especially high rates. Even after accounting for factors like age and health status, cancer survivors were still more likely to report kidney stones. These findings highlight the need for better kidney stone prevention and care strategies for cancer survivors, especially those at highest risk based on their cancer type.  \nAbstract  \nPurpose: To evaluate the prevalence and cancer-specific patterns of kidney stones among U.S. cancer survivors compared to non-cancer adults. Methods: This was a serial crosssectional, descriptive epidemiologic analysis of a US nationally representative sample from the National Health and Nutrition Examination Survey from 2007 to 2020 . Weighted prevalence of kidney stones was estimated for both non-cancer adults and cancer survivors by study cycle. Multivariable logistic regression was","cbCaifQLXW0ZMP3D","https://ap.wps.com/l/cbCaifQLXW0ZMP3D","pdf",622701,16,"English","# Simple Summary\n# Abstract\n# Keywords\n# Introduction\n## Study Rationale and Background","[{\"question\":\"What was the purpose of the study?\",\"answer\":\"To evaluate the prevalence and cancer-specific patterns of kidney stones among U.S. cancer survivors compared to non-cancer adults.\"},{\"question\":\"How were kidney-stone prevalence and associated factors analyzed?\",\"answer\":\"The study used serial cross-sectional NHANES data from 2007 to 2020, estimated weighted prevalence by survey cycle, and applied multivariable logistic regression to examine factors linked to kidney stones.\"},{\"question\":\"How did kidney-stone prevalence change from earlier to later periods (2007–2008 to 2017–2020)?\",\"answer\":\"Kidney-stone prevalence rose in both non-cancer adults and cancer survivors, and it was consistently higher among cancer survivors throughout the study period.\"}]","Trend and Cancer-Specific Prevalence of Kidney Stones Among US Cancer Survivors, 2007-2020 | PDF",1790192999]